ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors

Qin, Tianyu; Guo, Ensong; Lu, Funian; Fu, Yu; Liu, Si; Xiao, Rourou; Wu, Xue; Liu, Chen; He, Chao; Wang, Zizhuo; Qin, Xu; Hu, Dianxing; You, Lixin; Li, Fuxia; Li, Xi; Huang, Xiaoyuan; Ma, Ding; Xu, Xiaoyan; Yang, Bin*; Fan, Junpeng*华中科技大学; 南方医科大学
Aging-US2021-12-15
2被引17阅读
引用收藏
分享

摘要

Ongoing pandemic and potential resurgence of Coronavirus disease 2019 (COVID-19) has prompted urgent efforts to investigate the immunological memory of convalescent patients, especially in patients with active cancers. Here we performed single-cell RNA sequencing in peripheral blood samples of 3 healthy donors (HDs), 4 COVID-19 patients (Covs) and 4 COVID-19 patients with active gynecological tumor (TCs) pre- and post- antitumor treatment. All Covs patients had recovered from their acute infection. Interestingly, the molecular features of PBMCs in TCs are similar to that in Covs, suggesting that convalescent COVID-19 with gynecologic tumors do not have major immunological changes and may be protected against reinfection similar to COVID19 patients without tumors. Moreover, the chemotherapy given to these patients mainly caused neutropenia, while having little effect on the proportion and functional phenotype of T and B cells, and T cell clonal expansion. Notably, anti-PD-L1 treatment massively increased cytotoxic scores of NK cells, and T cells, and facilitated clonal expansion of T cells in these patients. It is likely that T cells could protect patients from SARSCoV-2 virus reinfection and anti-PD-L1 treatment can enhance the anti-viral activity of the T cells.

学科与关键词

关键词
COVID-19tumorchemotherapyICIssingle cell sequencing
相关
加载中…
  • Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19
    Huang, Yongsheng; Yu, Jing; Li, Dan; He, Kai; Liu, Wenyang; Wang, Lin; Chen, Yeshan*; Xie, Conghua*; Wu, Xiaowei*Scientific Reports, 2021, 11(1): 17381.
  • Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient
    Ren, Yanyu; Li, Runrong; Feng, Hanxiao; Xie, Jieying; Gao, Lin; Chu, Shuai; Li, Yan*; Meng, Fanliang*; Ning, Yunshan*Frontiers in Immunology, 2022, 13: 985187.被引 5
  • PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
    Chen, Xiangyu; Lin, Yao; Yue, Shuai; Yang, Yang; Yang, Xiaofan; He, Junjian; Gao, Leiqiong; Li, Zhirong; Hu, Li; Tang, Jianfang; Wang, Yifei; Tian, Qin; Hao, Yaxing; Xu, Lifan; Huang, Qizhao; Cao, Yingjiao*; Ye, Lilin*Vaccine, 2023, 41(34): 4986-4995.
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2021-12-15
卷期
第 13 卷, 第 23 期
页码
24943-24962
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Talent Science Start-up Fund of Tongji Hospital

作者

  • Q

    Qin, Tianyu (第一作者)

    huazhong univ sci & technol

  • G

    Guo, Ensong

    huazhong univ sci & technol

查看全部 20 位作者收起作者
  • L

    Lu, Funian

    huazhong univ sci & technol

  • F

    Fu, Yu

    huazhong univ sci & technol

  • L

    Liu, Si

    huazhong univ sci & technol

  • X

    Xiao, Rourou

    huazhong univ sci & technol

  • W

    Wu, Xue

    huazhong univ sci & technol

  • L

    Liu, Chen

    huazhong univ sci & technol

  • H

    He, Chao

    huazhong univ sci & technol

  • W

    Wang, Zizhuo

    huazhong univ sci & technol

  • Q

    Qin, Xu

    huazhong univ sci & technol

  • H

    Hu, Dianxing

    huazhong univ sci & technol

  • Y

    You, Lixin

    huazhong univ sci & technol

  • L

    Li, Fuxia

    southern med univ

  • L

    Li, Xi

    huazhong univ sci & technol

  • H

    Huang, Xiaoyuan

    huazhong univ sci & technol

  • M

    Ma, Ding

    huazhong univ sci & technol

  • X

    Xu, Xiaoyan

    huazhong univ sci & technol

  • Y

    Yang, Bin (通讯)

    huazhong univ sci & technol

  • F

    Fan, Junpeng (通讯)

    huazhong univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417